Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAGNETIC-AF
NCT07632157Phase 3Not yet recruiting
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 3 trial of magnesium sulfate in Atrial fibrillation (AFib), atrial flutter (AFL), sponsored by Wake Forest University Health Sciences. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Atrial fibrillation (AFib)atrial flutter (AFL)
Beyond the preview
Go deeper on NCT07632157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07632157.